Design patents can play an important role in protecting a tech start-up’s innovations and creating competitive advantage, whether they are the only available protection or part of a larger patent
Continue Reading Success by Design: A New Option for Expedited Patent Protection in Foreign Countries
Roman Fayerberg
Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and patent infringement and validity matters. He also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.
Roman has represented clients ranging from start-ups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.
Greenberg Traurig Attorneys Participate in J.P. Morgan Healthcare Conference & Biotech Showcase
The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase was held in January in San Francisco, Calif. The conference is the biggest health care investing event of the year, attracting thousands of medical device, biotechnology, and pharmaceutical executives and investors in attendance from around the world. Numerous Israeli companies participated in the conference, including a group of seven health care technology companies that presented at the Health Evolution Summit, “Connecting Health Leaders.”
More than 30 Greenberg Traurig attorneys from offices around the world attended the conference to provide support to existing clients and forge new connections. In attendance from the firm’s Israel Practice were Bob Grossman, co-chair of the Israel Practice, David Dykeman, co-chair of the firm’s Life Sciences & Medical Technology Group, and Roman Fayerberg, an IP shareholder in the Boston office.Continue Reading Greenberg Traurig Attorneys Participate in J.P. Morgan Healthcare Conference & Biotech Showcase